 OUTLINE: This is a randomized, multicenter study. Patients are stratified according to histology ductal adenocarcinoma vs ampullary or other pancreatic malignancy, resection margin status, and participating country. Patients are randomized to 1 of 2 treatment arms. Randomization for patients with ampullary or other pancreatic malignancy includes an observation arm. 